Skip to content
Finance & Wealth

Anthem Net Worth: Analyzing the Financial Power of Elevance Health in 2026

In this article

As of 2026, the net worth of the company formerly known as Anthem, Inc., now operating as Elevance Health (ELV), is measured by a market capitalization of approximately $145 billion to $155 billion, while its total stockholders' equity (accounting net worth) stands at roughly $48 billion. This valuation reflects the company’s evolution from a traditional health insurer into a diversified "whole health" services giant.

The transition from the "Anthem" brand to Elevance Health, which was finalized in mid-2022, signaled a significant shift in the company’s business model. While many consumers still recognize the Anthem name through its Blue Cross Blue Shield licenses in various states, the corporate entity's financial value is now driven by a broader ecosystem of pharmacy benefit management, behavioral health services, and complex care delivery. To understand the "Anthem net worth" in the context of 2026, one must look at both the market's perception of its future earnings and the tangible assets held on its balance sheet.

The Rebrand and Its Impact on Corporate Valuation

The rebranding of Anthem, Inc. to Elevance Health was not merely a cosmetic change. It was a strategic move to decouple the corporation’s diverse service offerings from the regulatory and geographic constraints associated with the "Anthem" and "Blue Cross Blue Shield" trademarks. This shift has had a direct impact on the company’s valuation by allowing it to compete more aggressively in the health services space through its Carelon brand.

By 2026, Carelon has become a primary engine for the company’s net worth growth. Unlike traditional insurance underwriting, which is often subject to strict medical loss ratio (MLR) regulations that limit profit margins, the health services provided under Carelon allow for higher-margin revenue streams. This diversification has led to a "valuation re-rating" by Wall Street, where the company is increasingly valued like a technology-enabled services firm rather than a utility-like insurer.

Market Capitalization vs. Book Value

When discussing the net worth of a Fortune 50 company like Elevance Health, it is vital to distinguish between Market Capitalization and Book Value (Total Equity).

Market Capitalization

This is the value the stock market assigns to the company. It is calculated by multiplying the total number of outstanding shares by the current stock price. In 2026, Elevance Health’s market cap reflects investor confidence in its ability to navigate a complex regulatory environment, its expansion into Medicare Advantage, and its successful integration of AI-driven clinical analytics. The market value typically sits much higher than the book value because it accounts for "goodwill," brand recognition, and future earnings potential.

Book Value (Accounting Net Worth)

The book value represents the company’s total assets minus its total liabilities. For Elevance Health, assets include massive investment portfolios (largely consisting of fixed-income securities), cash equivalents, and premiums receivable. Liabilities primarily consist of medical claims reserves—money set aside to pay for healthcare services already provided to members but not yet billed. As of 2026, the company’s book value has grown steadily due to consistent retained earnings and strategic asset management.

Is Anthem Worth It? _ Is Anthem Worth Playing Now? A Comprehensive ...
Is Anthem Worth It? _ Is Anthem Worth Playing Now? A Comprehensive ...

Key Financial Indicators (2024–2026)

To grasp the scale of the company’s financial standing, we examine the growth trajectory of its revenue, net income, and total equity over the past few years.

Metric 2024 (Actual/Reported) 2025 (Estimated) 2026 (Projected/Current)
Annual Revenue $176 Billion $185 Billion $194 Billion
Net Income $6.5 Billion $7.1 Billion $7.8 Billion
Total Assets $112 Billion $118 Billion $125 Billion
Total Equity (Net Worth) $41 Billion $44 Billion $48 Billion
Market Capitalization $130 Billion $142 Billion $152 Billion

Note: 2026 figures are based on current market performance and growth trends observed in the healthcare sector.

Revenue Streams Driving Net Worth Growth

The "net worth" of Elevance Health is supported by four primary pillars. The stability and growth of these segments determine the company's long-term financial health.

1. Commercial and Specialty Business

This remains the legacy core of the "Anthem" identity. It includes employer-sponsored insurance and individual plans sold on the Affordable Care Act (ACA) exchanges. By 2026, this segment has focused heavily on "Value-Based Care" models, which reward providers for health outcomes rather than the volume of services. This transition reduces long-term costs and stabilizes the company’s profit margins.

2. Government Business (Medicare and Medicaid)

The aging U.S. population has made the Medicare Advantage market a critical component of Elevance Health’s valuation. Despite periodic regulatory changes to reimbursement rates from the Centers for Medicare & Medicaid Services (CMS), the company’s ability to manage high-acuity patients efficiently has allowed it to maintain a significant market share. Similarly, its Medicaid managed care contracts provide a steady, albeit lower-margin, revenue floor.

3. Carelon Health Services

Carelon is the brand that houses the company’s most profitable ventures: pharmacy benefit management (PBM), behavioral health, and medical benefit management. By internalizing these services, Elevance Health captures the "spread" that used to go to third-party vendors. In 2026, Carelon contributes nearly 30% of the company’s overall earnings, making it the fastest-growing contributor to the corporate net worth.

4. Digital Health and AI Integration

A significant portion of the company’s assets in 2026 is tied up in proprietary technology. Elevance Health has invested billions into data analytics to predict health risks before they become expensive emergency room visits. This "predictive health" capability is a "hidden" asset that increases the company's valuation in the eyes of institutional investors.

Strategic Acquisitions and Asset Allocation

The net worth of Elevance Health is also a product of its aggressive acquisition strategy. Since 2020, the company has acquired several specialty care providers, home health agencies, and fintech platforms aimed at streamlining healthcare payments.

Significant acquisitions in recent years include:

  • BioPlus: A specialty pharmacy that expanded the company’s reach into complex chronic disease management.
  • Home Health Providers: By owning the delivery of care in the home, the company reduces the need for expensive hospital stays, directly improving its bottom line.
  • Paragon Healthcare: Strengthening its infusion services and specialty pharmacy capabilities.

These acquisitions are reflected as "Intangible Assets" and "Goodwill" on the balance sheet. While these are not physical assets like buildings, they represent the strategic value of the businesses acquired and play a massive role in the total valuation of the company.

Regulatory Risks and Valuation Headwinds

No analysis of a healthcare giant’s net worth is complete without considering the risks. The primary threat to Elevance Health’s valuation is legislative change.

  • PBM Transparency Legislation: In 2024 and 2025, several federal bills targeted the transparency of pharmacy benefit managers. As Elevance Health grows its CarelonRx segment, it faces increased scrutiny regarding how it negotiates drug prices and whether it passes those savings to consumers.
  • Medicare Advantage Star Ratings: The company’s net worth is sensitive to its "Star Ratings" from CMS. Lower ratings lead to reduced bonus payments, which can impact annual revenue by hundreds of millions of dollars.
  • Medical Cost Trends: Inflation in the healthcare sector—specifically rising labor costs for nurses and physicians—puts pressure on insurance margins. If Elevance Health cannot raise premiums fast enough to cover these costs, its net worth growth could stall.

Comparative Market Position

In the landscape of 2026, Elevance Health remains one of the "Big Three" managed care organizations in the United States, alongside UnitedHealth Group and Cigna.

  • UnitedHealth Group (UNH): Remains the largest by market cap (often exceeding $500 billion), largely due to its massive Optum health services division.
  • Elevance Health (ELV): Occupies the second or third spot, depending on the fluctuations in its Blue Cross Blue Shield membership growth.
  • Cigna (CI): Closely competes with Elevance in the health services space through its Evernorth brand.

Elevance Health’s unique advantage is its deep-rooted presence in local markets through its 14-state Blue Cross Blue Shield licenses, providing a level of brand trust that "pure-play" insurers often lack.

Frequently Asked Questions

What was Anthem's net worth before the rebrand?

Prior to rebranding as Elevance Health in 2022, Anthem, Inc. had a market capitalization of approximately $115 billion. The rebrand was part of a larger strategy to expand beyond insurance, which has since increased the company's total valuation and equity.

Is the "Anthem" name still used in 2026?

Yes. While the parent company is Elevance Health, the "Anthem Blue Cross" and "Anthem Blue Cross and Blue Shield" names are still used for insurance products in the states where the company holds those specific licenses. This dual-brand strategy allows the company to maintain consumer trust while expanding corporate operations.

How does the stock price affect the company's net worth?

The stock price directly determines the Market Capitalization, which is the market's version of net worth. If the stock price rises due to strong quarterly earnings or positive regulatory news, the company's market net worth increases, even if its physical assets remain the same.

Does Elevance Health pay dividends to shareholders?

Yes. Elevance Health has a history of consistent dividend growth. For investors, these dividends are a return on the company's "net worth." By 2026, the company continues to use its strong cash flow to both pay dividends and buy back shares, which helps support the stock price and overall market valuation.

Who is the largest shareholder of Elevance Health?

The company is primarily owned by large institutional investors. Major firms such as The Vanguard Group, BlackRock, and State Street Corporation typically hold the largest percentages of shares, as is common with most S&P 500 companies.

Expert Recommendation for Investors and Analysts

When evaluating the net worth of a company like Elevance Health in 2026, look beyond the "Insurance" label. The true value lies in the synergy between its insurance arm and its services arm (Carelon).

If you are assessing the company's financial stability, prioritize the Debt-to-Equity ratio and the Medical Loss Ratio. A stable MLR (typically around 86-88%) indicates that the company is effectively pricing its premiums relative to the care its members require. For those tracking the "Anthem" legacy, monitor the company’s expansion into non-regulated health services, as this is where the most significant "net worth" appreciation will likely occur in the coming decade.